(DOW) Dow - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2605571031
Stock: Plastics, Chemicals, Coatings, Polymers, Resins
Total Rating 38
Risk 70
Buy Signal 0.19
| Risk 5d forecast | |
|---|---|
| Volatility | 46.8% |
| Relative Tail Risk | -8.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.31 |
| Alpha | -9.96 |
| Character TTM | |
|---|---|
| Beta | 0.928 |
| Beta Downside | 1.041 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.16% |
| CAGR/Max DD | -0.09 |
EPS (Earnings per Share)
Revenue
Description: DOW Dow March 04, 2026
Dow Inc. is a global materials science company. It provides solutions for packaging, infrastructure, mobility, and consumer markets. The company operates in the Commodity Chemicals sub-industry.
Dows business model is segmented into three areas. The Packaging & Specialty Plastics segment focuses on products like polyethylene and other ethylene derivatives. The Industrial Intermediates & Infrastructure segment produces polyurethanes and chlor-alkali products. The Performance Materials & Coatings segment offers architectural and industrial coatings, alongside acrylics and silicon-based materials.
The company also has operations in property and casualty insurance and reinsurance, diversifying its revenue streams beyond core chemical manufacturing.
Further research on platforms like ValueRay can provide deeper insights into Dows financial performance and market position.
Headlines to watch out for
- Global economic growth dictates demand for packaging and industrial chemicals
- Energy prices directly impact raw material and production costs
- Regulatory changes on chemical production and emissions increase compliance expenses
- Competition from Asian manufacturers pressures product pricing
- Construction and automotive sector health influences specialty materials sales
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -2.62b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA -4.20 > 1.0 |
| NWC/Revenue: 22.22% < 20% (prev 14.67%; Δ 7.55% < -1%) |
| CFO/TA 0.03 > 3% & CFO 1.78b > Net Income -2.62b |
| Net Debt (15.78b) to EBITDA (1.22b): 12.94 < 3 |
| Current Ratio: 1.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (718.2m) vs 12m ago 1.86% < -2% |
| Gross Margin: 6.22% > 18% (prev 0.10%; Δ 611.4% > 0.5%) |
| Asset Turnover: 69.00% > 50% (prev 74.97%; Δ -5.97% > 0%) |
| Interest Coverage Ratio: -1.80 > 6 (EBITDA TTM 1.22b / Interest Expense TTM 897.0m) |
Altman Z'' 1.98
| A: 0.15 (Total Current Assets 18.06b - Total Current Liabilities 9.18b) / Total Assets 58.54b |
| B: 0.29 (Retained Earnings 16.78b / Total Assets 58.54b) |
| C: -0.03 (EBIT TTM -1.61b / Avg Total Assets 57.92b) |
| D: 0.22 (Book Value of Equity 9.13b / Total Liabilities 41.02b) |
| Altman-Z'' Score: 1.98 = BBB |
Beneish M -2.55
| DSRI: 1.04 (Receivables 6.64b/6.86b, Revenue 39.97b/42.96b) |
| GMI: 1.66 (GM 6.22% / 10.34%) |
| AQI: 0.95 (AQ_t 0.29 / AQ_t-1 0.30) |
| SGI: 0.93 (Revenue 39.97b / 42.96b) |
| TATA: -0.08 (NI -2.62b - CFO 1.78b) / TA 58.54b) |
| Beneish M-Score: -2.55 (Cap -4..+1) = A |
What is the price of DOW shares?
As of March 23, 2026, the stock is trading at USD 36.65 with a total of 14,991,342 shares traded.
Over the past week, the price has changed by +1.81%, over one month by +22.39%, over three months by +58.34% and over the past year by +7.83%.
Over the past week, the price has changed by +1.81%, over one month by +22.39%, over three months by +58.34% and over the past year by +7.83%.
Is DOW a buy, sell or hold?
Dow has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold DOW.
- StrongBuy: 4
- Buy: 0
- Hold: 16
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the DOW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35.1 | -4.2% |
| Analysts Target Price | 35.1 | -4.2% |
DOW Fundamental Data Overview March 18, 2026
P/E Forward = 714.2857
P/S = 0.6482
P/B = 1.6183
P/EG = 35.6436
Revenue TTM = 39.97b USD
EBIT TTM = -1.61b USD
EBITDA TTM = 1.22b USD
Long Term Debt = 17.85b USD (from longTermDebt, last quarter)
Short Term Debt = 652.0m USD (from shortTermDebt, last quarter)
Debt = 19.60b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.78b USD (from netDebt column, last quarter)
Enterprise Value = 41.69b USD (25.91b + Debt 19.60b - CCE 3.82b)
Interest Coverage Ratio = -1.80 (Ebit TTM -1.61b / Interest Expense TTM 897.0m)
EV/FCF = -15.97x (Enterprise Value 41.69b / FCF TTM -2.61b)
FCF Yield = -6.26% (FCF TTM -2.61b / Enterprise Value 41.69b)
FCF Margin = -6.53% (FCF TTM -2.61b / Revenue TTM 39.97b)
Net Margin = -6.56% (Net Income TTM -2.62b / Revenue TTM 39.97b)
Gross Margin = 6.22% ((Revenue TTM 39.97b - Cost of Revenue TTM 37.48b) / Revenue TTM)
Gross Margin QoQ = 5.79% (prev 6.91%)
Tobins Q-Ratio = 0.71 (Enterprise Value 41.69b / Total Assets 58.54b)
Interest Expense / Debt = 1.12% (Interest Expense 219.0m / Debt 19.60b)
Taxrate = 21.0% (US default 21%)
NOPAT = -1.28b (EBIT -1.61b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.97 (Total Current Assets 18.06b / Total Current Liabilities 9.18b)
Debt / Equity = 1.22 (Debt 19.60b / totalStockholderEquity, last quarter 16.01b)
Debt / EBITDA = 12.94 (Net Debt 15.78b / EBITDA 1.22b)
Debt / FCF = -6.05 (negative FCF - burning cash) (Net Debt 15.78b / FCF TTM -2.61b)
Total Stockholder Equity = 16.89b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.53% (Net Income -2.62b / Total Assets 58.54b)
RoE = -15.53% (Net Income TTM -2.62b / Total Stockholder Equity 16.89b)
RoCE = -4.65% (EBIT -1.61b / Capital Employed (Equity 16.89b + L.T.Debt 17.85b))
RoIC = -3.83% (negative operating profit) (NOPAT -1.28b / Invested Capital 33.27b)
WACC = 5.65% (E(25.91b)/V(45.50b) * Re(9.25%) + D(19.60b)/V(45.50b) * Rd(1.12%) * (1-Tc(0.21)))
Discount Rate = 9.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.03%
[DCF] Fair Price = unknown (Cash Flow -2.61b)
EPS Correlation: -90.29 | EPS CAGR: -56.16% | SUE: 1.06 | # QB: 1
Revenue Correlation: -89.18 | Revenue CAGR: -11.98% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.16 | Chg7d=+0.104 | Chg30d=+0.194 | Revisions Net=+3 | Analysts=11
EPS current Year (2026-12-31): EPS=-0.20 | Chg7d=+0.157 | Chg30d=+0.188 | Revisions Net=+2 | Growth EPS=+78.9% | Growth Revenue=+0.4%
EPS next Year (2027-12-31): EPS=0.73 | Chg7d=+0.120 | Chg30d=+0.124 | Revisions Net=+3 | Growth EPS=+470.1% | Growth Revenue=+3.3%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
P/S = 0.6482
P/B = 1.6183
P/EG = 35.6436
Revenue TTM = 39.97b USD
EBIT TTM = -1.61b USD
EBITDA TTM = 1.22b USD
Long Term Debt = 17.85b USD (from longTermDebt, last quarter)
Short Term Debt = 652.0m USD (from shortTermDebt, last quarter)
Debt = 19.60b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.78b USD (from netDebt column, last quarter)
Enterprise Value = 41.69b USD (25.91b + Debt 19.60b - CCE 3.82b)
Interest Coverage Ratio = -1.80 (Ebit TTM -1.61b / Interest Expense TTM 897.0m)
EV/FCF = -15.97x (Enterprise Value 41.69b / FCF TTM -2.61b)
FCF Yield = -6.26% (FCF TTM -2.61b / Enterprise Value 41.69b)
FCF Margin = -6.53% (FCF TTM -2.61b / Revenue TTM 39.97b)
Net Margin = -6.56% (Net Income TTM -2.62b / Revenue TTM 39.97b)
Gross Margin = 6.22% ((Revenue TTM 39.97b - Cost of Revenue TTM 37.48b) / Revenue TTM)
Gross Margin QoQ = 5.79% (prev 6.91%)
Tobins Q-Ratio = 0.71 (Enterprise Value 41.69b / Total Assets 58.54b)
Interest Expense / Debt = 1.12% (Interest Expense 219.0m / Debt 19.60b)
Taxrate = 21.0% (US default 21%)
NOPAT = -1.28b (EBIT -1.61b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.97 (Total Current Assets 18.06b / Total Current Liabilities 9.18b)
Debt / Equity = 1.22 (Debt 19.60b / totalStockholderEquity, last quarter 16.01b)
Debt / EBITDA = 12.94 (Net Debt 15.78b / EBITDA 1.22b)
Debt / FCF = -6.05 (negative FCF - burning cash) (Net Debt 15.78b / FCF TTM -2.61b)
Total Stockholder Equity = 16.89b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.53% (Net Income -2.62b / Total Assets 58.54b)
RoE = -15.53% (Net Income TTM -2.62b / Total Stockholder Equity 16.89b)
RoCE = -4.65% (EBIT -1.61b / Capital Employed (Equity 16.89b + L.T.Debt 17.85b))
RoIC = -3.83% (negative operating profit) (NOPAT -1.28b / Invested Capital 33.27b)
WACC = 5.65% (E(25.91b)/V(45.50b) * Re(9.25%) + D(19.60b)/V(45.50b) * Rd(1.12%) * (1-Tc(0.21)))
Discount Rate = 9.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.03%
[DCF] Fair Price = unknown (Cash Flow -2.61b)
EPS Correlation: -90.29 | EPS CAGR: -56.16% | SUE: 1.06 | # QB: 1
Revenue Correlation: -89.18 | Revenue CAGR: -11.98% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.16 | Chg7d=+0.104 | Chg30d=+0.194 | Revisions Net=+3 | Analysts=11
EPS current Year (2026-12-31): EPS=-0.20 | Chg7d=+0.157 | Chg30d=+0.188 | Revisions Net=+2 | Growth EPS=+78.9% | Growth Revenue=+0.4%
EPS next Year (2027-12-31): EPS=0.73 | Chg7d=+0.120 | Chg30d=+0.124 | Revisions Net=+3 | Growth EPS=+470.1% | Growth Revenue=+3.3%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)